Haemonetics Corp (HAE) stock
HAENYSESurgical & Medical Instruments & ApparatusFiscal year ends April 3
Financials through Q2 FY2027, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3064% above fair value
$122.94+0.23 (+0.19%)
Close on Nov 13, 2026Market cap $5.59BP/E 54.9Yield –
Haemonetics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Haemonetics's enterprise value was $6.35B on Nov 11, 2026, against $4.73B a year earlier. Over the last 5 years it ranged from $3.06B to $6.39B, with a median of $4.52B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $6.35B | +35.8% |
| 2025 | Dec 31, 2025 | $4.68B | -3.8% |
| 2024 | Dec 31, 2024 | $4.86B | +2.3% |
| 2023 | Dec 29, 2023 | $4.75B | +4.2% |
| 2022 | Dec 30, 2022 | $4.56B | +38.2% |
| 2021 | Dec 31, 2021 | $3.30B | -46.9% |
| 2020 | Dec 31, 2020 | $6.21B | +2.2% |
| 2019 | Dec 31, 2019 | $6.07B | +14.4% |
| 2018 | Dec 31, 2018 | $5.31B | +68.9% |
| 2017 | Dec 29, 2017 | $3.14B | +35.4% |
| 2016 | Dec 30, 2016 | $2.32B | +18.0% |
| 2015 | Dec 31, 2015 | $1.97B | -11.5% |
| 2014 | Dec 31, 2014 | $2.22B | -10.3% |
| 2013 | Dec 31, 2013 | $2.48B | +3.1% |
| 2012 | Dec 31, 2012 | $2.40B | +77.5% |
| 2011 | Dec 30, 2011 | $1.35B | -7.7% |
| 2010 | Dec 31, 2010 | $1.46B | +13.8% |
| 2009 | Dec 31, 2009 | $1.29B | – |
See a number that looks wrong?